Anti-pigmentary effect of (-)-4-hydroxysattabacin from the marine-derived bacterium Bacillus sp.

Kyuri Kim; Alain S. Leutou; Haein Jeong; Dayoung Kim; Chi Nam Seong; Sang Jip Nam; Kyung Min Lim

doi:10.3390/md15050138

Anti-pigmentary effect of (-)-4-hydroxysattabacin from the marine-derived bacterium Bacillus sp.

Kyuri Kim, Alain S. Leutou, Haein Jeong, Dayoung Kim, Chi Nam Seong, Sang Jip Nam, Kyung Min Lim

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

Bioactivity-guided isolation of a crude extract from a culture broth of Bacillus sp. has led to the isolation of (-)-4-hydroxysattabacin (1). The inhibitory effect of (-)-4-hydroxysattabacin (1) was investigated on melanogenesis in the murine melanoma cell line, B16F10, and human melanoma cell line, MNT-1, as well as a pigmented 3D-human skin model. (-)-4-Hydroxysattabacin treatment decreased melanin contents in a dose-dependent manner in α-melanocyte stimulating hormone (α-MSH)-stimulated B16F10 cells. Quantitative real time PCR (qRT-PCR) demonstrated that treatment with (-)-4-hydroxysattabacin down-regulated several melanogenic genes, including tyrosinase, tyrosinase-related protein 1 (TRP-1), and tyrosinase-related protein 2 (TRP-2) while their enzymatic activities were unaffected. The anti-melanogenic effects of (-)-4-hydroxysattabacin were further demonstrated in a pigmented 3D human epidermal skin model, Melanoderm™, and manifested as whitening and regression of melanocyte activation in the tissue.

Original language	English
Article number	138
Journal	Marine Drugs
Volume	15
Issue number	5
DOIs	https://doi.org/10.3390/md15050138
State	Published - May 2017

Bibliographical note

Funding Information:
The present study was supported by a grant of the Korean Health Technology R and D Project, Ministry of Health and Welfare, Republic of Korea (Grant No. HN15C0102) and by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT and Future Planning (NRF- 2014R1A1A1003492).

Publisher Copyright:
© 2017 by the authors. Licensee MDPI.

Keywords

(-)-4-Hydroxysattabacin
Anti-pigmentary effect
Bacillus sp.
Marine-derived
Melanogenesis

Access to Document

10.3390/md15050138

Cite this

@article{5592f441c15f4661b88c98572b676298,

title = "Anti-pigmentary effect of (-)-4-hydroxysattabacin from the marine-derived bacterium Bacillus sp.",

abstract = "Bioactivity-guided isolation of a crude extract from a culture broth of Bacillus sp. has led to the isolation of (-)-4-hydroxysattabacin (1). The inhibitory effect of (-)-4-hydroxysattabacin (1) was investigated on melanogenesis in the murine melanoma cell line, B16F10, and human melanoma cell line, MNT-1, as well as a pigmented 3D-human skin model. (-)-4-Hydroxysattabacin treatment decreased melanin contents in a dose-dependent manner in α-melanocyte stimulating hormone (α-MSH)-stimulated B16F10 cells. Quantitative real time PCR (qRT-PCR) demonstrated that treatment with (-)-4-hydroxysattabacin down-regulated several melanogenic genes, including tyrosinase, tyrosinase-related protein 1 (TRP-1), and tyrosinase-related protein 2 (TRP-2) while their enzymatic activities were unaffected. The anti-melanogenic effects of (-)-4-hydroxysattabacin were further demonstrated in a pigmented 3D human epidermal skin model, Melanoderm{\texttrademark}, and manifested as whitening and regression of melanocyte activation in the tissue.",

keywords = "(-)-4-Hydroxysattabacin, Anti-pigmentary effect, Bacillus sp., Marine-derived, Melanogenesis",

author = "Kyuri Kim and Leutou, {Alain S.} and Haein Jeong and Dayoung Kim and Seong, {Chi Nam} and Nam, {Sang Jip} and Lim, {Kyung Min}",

note = "Funding Information: The present study was supported by a grant of the Korean Health Technology R and D Project, Ministry of Health and Welfare, Republic of Korea (Grant No. HN15C0102) and by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT and Future Planning (NRF- 2014R1A1A1003492). Publisher Copyright: {\textcopyright} 2017 by the authors. Licensee MDPI.",

year = "2017",

month = may,

doi = "10.3390/md15050138",

language = "English",

volume = "15",

journal = "Marine Drugs",

issn = "1660-3397",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "5",

}

TY - JOUR

T1 - Anti-pigmentary effect of (-)-4-hydroxysattabacin from the marine-derived bacterium Bacillus sp.

AU - Kim, Kyuri

AU - Leutou, Alain S.

AU - Jeong, Haein

AU - Kim, Dayoung

AU - Seong, Chi Nam

AU - Nam, Sang Jip

AU - Lim, Kyung Min

N1 - Funding Information: The present study was supported by a grant of the Korean Health Technology R and D Project, Ministry of Health and Welfare, Republic of Korea (Grant No. HN15C0102) and by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT and Future Planning (NRF- 2014R1A1A1003492). Publisher Copyright: © 2017 by the authors. Licensee MDPI.

PY - 2017/5

Y1 - 2017/5

N2 - Bioactivity-guided isolation of a crude extract from a culture broth of Bacillus sp. has led to the isolation of (-)-4-hydroxysattabacin (1). The inhibitory effect of (-)-4-hydroxysattabacin (1) was investigated on melanogenesis in the murine melanoma cell line, B16F10, and human melanoma cell line, MNT-1, as well as a pigmented 3D-human skin model. (-)-4-Hydroxysattabacin treatment decreased melanin contents in a dose-dependent manner in α-melanocyte stimulating hormone (α-MSH)-stimulated B16F10 cells. Quantitative real time PCR (qRT-PCR) demonstrated that treatment with (-)-4-hydroxysattabacin down-regulated several melanogenic genes, including tyrosinase, tyrosinase-related protein 1 (TRP-1), and tyrosinase-related protein 2 (TRP-2) while their enzymatic activities were unaffected. The anti-melanogenic effects of (-)-4-hydroxysattabacin were further demonstrated in a pigmented 3D human epidermal skin model, Melanoderm™, and manifested as whitening and regression of melanocyte activation in the tissue.

AB - Bioactivity-guided isolation of a crude extract from a culture broth of Bacillus sp. has led to the isolation of (-)-4-hydroxysattabacin (1). The inhibitory effect of (-)-4-hydroxysattabacin (1) was investigated on melanogenesis in the murine melanoma cell line, B16F10, and human melanoma cell line, MNT-1, as well as a pigmented 3D-human skin model. (-)-4-Hydroxysattabacin treatment decreased melanin contents in a dose-dependent manner in α-melanocyte stimulating hormone (α-MSH)-stimulated B16F10 cells. Quantitative real time PCR (qRT-PCR) demonstrated that treatment with (-)-4-hydroxysattabacin down-regulated several melanogenic genes, including tyrosinase, tyrosinase-related protein 1 (TRP-1), and tyrosinase-related protein 2 (TRP-2) while their enzymatic activities were unaffected. The anti-melanogenic effects of (-)-4-hydroxysattabacin were further demonstrated in a pigmented 3D human epidermal skin model, Melanoderm™, and manifested as whitening and regression of melanocyte activation in the tissue.

KW - (-)-4-Hydroxysattabacin

KW - Anti-pigmentary effect

KW - Bacillus sp.

KW - Marine-derived

KW - Melanogenesis

UR - http://www.scopus.com/inward/record.url?scp=85019639772&partnerID=8YFLogxK

U2 - 10.3390/md15050138

DO - 10.3390/md15050138

M3 - Article

C2 - 28505073

AN - SCOPUS:85019639772

SN - 1660-3397

VL - 15

JO - Marine Drugs

JF - Marine Drugs

IS - 5

M1 - 138

ER -

Anti-pigmentary effect of (-)-4-hydroxysattabacin from the marine-derived bacterium Bacillus sp.

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this